Inhibitors of Hepatitis C Virus NS3.4A Protease: P2 Proline Variants

E-ISSN： 1875-628x|2|7|497-502

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.7, 2005-01, pp. : 497-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1403-1422

Bentham Science Publishers

Access to resources Recommend Favorite

In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus

Current Pharmaceutical Design, Vol. 20, Iss. 21, 2014-05 ,pp. : 3465-3477

Bentham Science Publishers

Access to resources Recommend Favorite

Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry

Current Medicinal Chemistry, Vol. 23, Iss. 29, 2016-10 ,pp. : 3404-3447

Bentham Science Publishers

Access to resources Recommend Favorite

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C NS3 protease inhibitors

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 663-665

Informa Healthcare

Access to resources Recommend Favorite